A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

Mostrar otras versiones (1)

BACKGROUND: Pancreatic carcinoma (PC) is an aggressive malignancy that lacks strategies for early detection. This study aimed to develop a coherent, high-throughput and non-discriminatory pipeline for the novel clinical biomarker discovery of PC. METHODS: We combined mass spectrometry (MS)-intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaohui, Zheng, Weimin, Wang, Wansheng, Shen, Huali, Liu, Linxiao, Lou, Wenhui, Wang, Xiaolin, Yang, Pengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729477/
https://www.ncbi.nlm.nih.gov/pubmed/29123261
http://dx.doi.org/10.1038/bjc.2017.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729477/
https://www.ncbi.nlm.nih.gov/pubmed/29123261
http://dx.doi.org/10.1038/bjc.2017.365

Ejemplares similares